Bronchial disorder
MONDO:0001358A disease involving the bronchus.
Also known as: bronchial disorder, bronchospasm, bronchus disease, bronchus disease or disorder, disease of bronchus, disease or disorder of bronchus, disorder of bronchus
1010 clinical trials for this condition and its sub-types, 19 tagged with Bronchial disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bronchial disorder
-
Asthma 724 trials · 819 incl. sub-types
8 sub-types
- Chronic asthma 114 trials · 156 incl. sub-types Sub-types →
- Childhood onset asthma 111 trials
- Allergic asthma 41 trials Sub-types →
- Acute asthma 39 trials · 40 incl. sub-types Sub-types →
- Status asthmaticus 26 trials
- Intrinsic asthma 4 trials · 12 incl. sub-types Sub-types →
- Cough variant asthma 3 trials
- Occupational asthma 3 trials
-
Bronchiectasis 118 trials · 119 incl. sub-types
1 sub-type
- Idiopathic bronchiectasis 3 trials Sub-types →
-
Bronchitis 24 trials · 50 incl. sub-types
2 sub-types
- Chronic bronchitis 23 trials
- Croup 5 trials
-
Bronchial neoplasm 20 trials · 38 incl. sub-types
5 sub-types
- Bronchus cancer 3 trials · 26 incl. sub-types Sub-types →
- Bronchial endocrine tumor 4 trials
- Bronchus adenoma 0 trials Sub-types →
- Endobronchial leiomyoma 0 trials
- Endobronchial lipoma 0 trials
-
Non-syndromic bridging bronchus 0 trials
Most studied deeper sub-types
-
Targeted pill shows promise for rare lung cancer, but trial stopped early
Disease control Stopped earlyThis phase 3 study tested a new drug called pralsetinib against standard chemotherapy for people with a specific type of advanced lung cancer that has a RET gene fusion. The goal was to see if pralsetinib could better delay cancer growth. The trial was terminated early, so full r…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Experimental asthma drug briquilimab fails to reach Late-Stage testing
Disease control Stopped earlyThis Phase 1 trial tested a single dose of briquilimab in 17 adults with mild-to-moderate allergic asthma to see if it was safe and could reduce asthma attacks triggered by allergens. The study was terminated early, meaning it did not continue as planned. The main goal was to che…
Phase 1 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:40 UTC
-
Anesthesia drug study halted after just 3 patients
Knowledge-focused Stopped earlyThis study aimed to see if skipping a type of muscle relaxant during general anesthesia could lower the risk of serious lung complications in high-risk surgery patients. The trial was terminated early after enrolling only 3 participants, so no meaningful conclusions can be drawn.…
Phase 4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC